仁川TP创业跳跃套餐支持企业实现投资引进等成果

仁川TP 初创企业-supported companies achieve 投资引进 and overseas 专利 results… 60 bio companies to receive support this year as well RudaCure Inc.: Series B investment of KRW 1.4 billion secured, 1st place in IR Competition, and more

仁川科技园 (仁川TP) announced on the 1st that RudaCure, a participant in the '初创企业 Leap Forward Package Support Program,' has achieved notable results including certifications and 投资引进 in recognition of the program's excellence.

The '初创企业 Leap Forward Package Support Program' is a program promoted by the 韩国初创企业 Agency and 仁川TP with support from the 中小企业部 and 仁川广域市. It provides 初创企业 with commercialization funding, specialized programs, and investment linkage support.

RudaCure, a company developing treatments for 干眼症 and 慢性疼痛, utilized the '2023 初创企业 Leap Forward Package Support Program' to verify the pain-relief 疗效 of its therapeutics and assess the presence of 异常发热副作用, thereby developing alternatives to narcotic and 非麻醉性镇痛药.

Through this, the company filed 3 overseas 专利s and obtained various certifications including Strong Small Enterprise, Performance-Sharing Company, and Talent Development SME. In November of last year, it participated in 'KIC 华盛顿 DC' and won 1st place in the IR Competition.

The company also demonstrated the excellence of its program by securing KRW 1.4 billion in investment during its participation in the support program, bringing cumulative Series B investment to KRW 3.4 billion.

RudaCure CEO Yongho Kim expressed his ambitions, saying, "Based on the PCT 专利 for the 疼痛治疗药 'RCI002' developed through the 初创企业 Leap Forward Package support, we plan to secure 知识产权 in multiple countries including 欧洲, 中国, and Latin America, and advance into the 全球市场."